Dicer ablation in osteoblasts by Runx2 driven cre-loxP recombination affects bone integrity, but not

Peng Liu1,2, Mario Baumgart2, Marco Groth2

  • 1Institute of Comparative Molecular Endocrinology (CME), Ulm University, Ulm, Germany.

Scientific Reports
|August 25, 2016
PubMed

Insights

Glucocorticoid-induced osteoporosis (GIO) involves microRNAs. Dicer-dependent microRNAs in bone cells play a minor role in GIO, as their absence did not alter the negative effects of glucocorticoids on bone formation.

Area of Science:

  • Molecular Biology
  • Endocrinology
  • Bone Biology

Background:

  • Glucocorticoid-induced osteoporosis (GIO) is a significant adverse effect of long-term glucocorticoid (GC) treatment.
  • GIO primarily occurs through suppressed bone formation and osteoblast differentiation, independent of GC receptor (GR) dimerization.
  • MicroRNAs are crucial regulators of osteoblast differentiation.

Purpose of the Study:

  • To investigate the role of Dicer-dependent microRNAs in GC-induced suppression of osteoblast differentiation.
  • To elucidate the GR dimer-dependent and -independent microRNA expression patterns under GC treatment.
  • To determine the functional significance of microRNAs in GIO pathogenesis.

Main Methods:

  • MicroRNA sequencing on dexamethasone-treated wild-type and GR dimer-deficient mesenchymal stromal cells.
  • Generation of mice with osteoblast-specific deletion of Dicer (Dicer(Runx2Cre)).
  • In vitro analysis of Dicer-deficient osteoblasts (proliferation, differentiation, mineralization) and in vivo GIO models.

Main Results:

  • GC treatment altered miRNA expression in a GR dimer-dependent and -independent manner.
  • Osteoblast-specific Dicer deletion resulted in growth retardation and impaired bone formation.
  • However, GIO induction showed similar bone formation reduction in Dicer(Runx2Cre) mice and controls.
  • GC treatment suppressed differentiation of Dicer-deficient osteoblasts to the same extent as wild-type cells.

Conclusions:

  • Dicer-dependent small RNA biogenesis in osteoblasts plays a minor role in the pathogenesis of GC-induced bone formation inhibition.
  • GC-induced suppression of osteoblast differentiation is largely independent of Dicer-dependent microRNAs.

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.6K
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.9K
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.9K
Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
11.2K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
4.1K
Bone Formation by Intramembranous Ossification01:29

Bone Formation by Intramembranous Ossification

Intramembranous ossification is one of the two processes involved in the development of bones within an embryo. The flat bones of the face, most of the cranial bones, and the clavicles are formed via this process. During intramembranous ossification, the bones develop directly from sheets of undifferentiated mesenchymal connective tissue.
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...
12.9K